OpenEvidence and Tandem have announced a strategic partnership aimed at removing one of healthcare’s most persistent bottlenecks: the gap between clinical decision-making and patient access to treatment.
The collaboration links OpenEvidence’s AI-powered clinical decision support directly with Tandem’s automation platform, which manages prescription workflows, prior authorizations, and affordability pathways. The goal is straightforward—turn evidence-based decisions into immediate, executable actions without administrative delay.
OpenEvidence already supports more than one million clinical consultations daily across the United States, providing clinicians with real-time, continuously updated guidance grounded in peer-reviewed research. Tandem builds on that decision point by automating the downstream process: generating prescriptions, submitting prior authorizations and appeals, routing medications to the appropriate pharmacy, and enrolling patients in financial support programmes where needed.
By connecting these capabilities, the partnership aims to eliminate the lag that often exists between diagnosis and treatment initiation—a delay that can be driven by payer requirements, manual workflows, and fragmented systems.
“Clinicians shouldn’t have to choose between delivering care and navigating administrative complexity,” said Ania Bilski, MD, VP of Clinical AI at OpenEvidence. “By partnering with Tandem, we’re removing friction from both clinical and operational workflows—so clinicians can focus on getting patients the right treatments, faster. We’re excited to partner with Tandem who has a similar mission to OpenEvidence to build great technology products and improve doctors' end to end experience, and ultimately drive the best patient outcomes.”
The partnership also reflects a broader trend toward embedding automation directly within clinical workflows, particularly within EHR environments where prescribing decisions are made. Tandem’s infrastructure operates across all drugs, insurance plans, and pharmacies in the U.S., automating approvals and reducing the risk of treatment abandonment due to cost or delays.
“As a practicing physician, I've seen how often the best treatment plans for patients are blocked by administrative complexity,” said Adam Harris, MD, Head of Clinical Intelligence at Tandem. “OpenEvidence helps clinicians make the right call. Tandem makes sure patients get the medicine they need. Together, we're closing a gap that has undercut doctors and limited patients for too long.”
By unifying clinical intelligence with execution, the partnership signals a shift toward more integrated, end-to-end care delivery—where the right decision is not only made, but acted upon immediately.
Click here for the original news story.